Cosciens Biopharma Stock Buy Hold or Sell Recommendation
| CSCI Stock | 2.90 0.05 1.75% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding COSCIENS Biopharma is 'Sell'. The recommendation algorithm takes into account all of COSCIENS Biopharma's available fundamental, technical, and predictive indicators you will find on this site.
Check out COSCIENS Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide. In addition, we conduct extensive research on individual companies such as COSCIENS and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards COSCIENS Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
COSCIENS |
Execute COSCIENS Biopharma Buy or Sell Advice
The COSCIENS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on COSCIENS Biopharma. Macroaxis does not own or have any residual interests in COSCIENS Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute COSCIENS Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
COSCIENS Biopharma Trading Alerts and Improvement Suggestions
| COSCIENS Biopharma generated a negative expected return over the last 90 days | |
| COSCIENS Biopharma has high historical volatility and very poor performance | |
| COSCIENS Biopharma was previously known as Aeterna Zentaris and was traded on NASDAQ Exchange under the symbol AEZS. | |
| The company reported the previous year's revenue of 7.26 M. Net Loss for the year was (3.55 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| COSCIENS Biopharma generates negative cash flow from operations |
COSCIENS Biopharma Returns Distribution Density
The distribution of COSCIENS Biopharma's historical returns is an attempt to chart the uncertainty of COSCIENS Biopharma's future price movements. The chart of the probability distribution of COSCIENS Biopharma daily returns describes the distribution of returns around its average expected value. We use COSCIENS Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of COSCIENS Biopharma returns is essential to provide solid investment advice for COSCIENS Biopharma.
| Mean Return | -0.45 | Value At Risk | -6.25 | Potential Upside | 5.34 | Standard Deviation | 3.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of COSCIENS Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
COSCIENS Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to COSCIENS Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that COSCIENS Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a COSCIENS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | 0.28 | |
σ | Overall volatility | 3.16 | |
Ir | Information ratio | -0.17 |
COSCIENS Biopharma Volatility Alert
COSCIENS Biopharma exhibits very low volatility with skewness of -0.18 and kurtosis of 1.5. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure COSCIENS Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact COSCIENS Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.COSCIENS Biopharma Fundamentals Vs Peers
Comparing COSCIENS Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze COSCIENS Biopharma's direct or indirect competition across all of the common fundamentals between COSCIENS Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as COSCIENS Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of COSCIENS Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing COSCIENS Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare COSCIENS Biopharma to competition |
| Fundamentals | COSCIENS Biopharma | Peer Average |
| Return On Equity | -0.66 | -0.31 |
| Return On Asset | -0.23 | -0.14 |
| Operating Margin | (1.61) % | (5.51) % |
| Current Valuation | (13.04 M) | 16.62 B |
| Shares Outstanding | 3.12 M | 571.82 M |
| Shares Owned By Insiders | 1.32 % | 10.09 % |
| Shares Owned By Institutions | 6.69 % | 39.21 % |
| Number Of Shares Shorted | 2.21 K | 4.71 M |
| Price To Book | 0.49 X | 9.51 X |
| Price To Sales | 2.66 X | 11.42 X |
| Revenue | 7.26 M | 9.43 B |
| EBITDA | (17.99 M) | 3.9 B |
| Net Income | (3.55 M) | 570.98 M |
| Total Debt | 3.59 M | 5.32 B |
| Book Value Per Share | 8.57 X | 1.93 K |
| Cash Flow From Operations | (2.73 M) | 971.22 M |
| Short Ratio | 1.64 X | 4.00 X |
| Earnings Per Share | (2.69) X | 3.12 X |
| Beta | 2.27 | -0.15 |
| Market Capitalization | 13.08 M | 19.03 B |
| Total Asset | 31.45 M | 29.47 B |
| Retained Earnings | 6.17 M | 9.33 B |
| Working Capital | 13.11 M | 1.48 B |
| Net Asset | 31.45 M |
COSCIENS Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as COSCIENS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 2.9 | |||
| Day Typical Price | 2.9 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.05 |
About COSCIENS Biopharma Buy or Sell Advice
When is the right time to buy or sell COSCIENS Biopharma? Buying financial instruments such as COSCIENS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having COSCIENS Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out COSCIENS Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of COSCIENS Biopharma. If investors know COSCIENS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.69) | Revenue Per Share 3.759 | Quarterly Revenue Growth 0.041 | Return On Assets (0.23) | Return On Equity (0.66) |
The market value of COSCIENS Biopharma is measured differently than its book value, which is the value of COSCIENS that is recorded on the company's balance sheet. Investors also form their own opinion of COSCIENS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is COSCIENS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because COSCIENS Biopharma's market value can be influenced by many factors that don't directly affect COSCIENS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between COSCIENS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSCIENS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSCIENS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.